eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
4/2018
vol. 69
 
Share:
Share:
more
 
 
abstract:
Original paper

EGOT lncRNA in head and neck squamous cell carcinomas

Tomasz Kolenda, Magdalena Kopczyńska, Kacper Guglas, Anna Teresiak, Renata Bliźniak, Izabela Łasińska, Jacek Mackiewicz, Katarzyna Lamperska

Pol J Pathol 2018; 69 (4): 356-365
Online publish date: 2019/01/31
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Head and neck squamous cell carcinomas (HNSCCs) are one of the most challenging cancers to cure. In this study, we focused on eosinophil granule ontogeny transcript (EGOT), a transcriptional regulator of granule protein expression during eosinophil development that has been previously associated with cancers.

Expression levels of EGOT and other selected genes as well as clinical pathology data from HNSCC samples, were obtained from The Cancer Genome Atlas (TCGA) and analysed using GraphPad Prism 5. Our results indicated that the expression of EGOT is slightly down-regulated in HNSCC, depending on tumour grade and location, and is only up-regulated in grade 4 tumours and those located in the pharynx. EGOT expression levels were found to vary according to age, N-stage, grade, lymph node dissection and human papillomavirus (HPV) infection.

Patients with higher levels of EGOT expression have longer disease-free survival and overall survival outcomes. Further analysis revealed that EGOT targets are associated with cell division, proliferation, protein modification, drug response and cell motility. Taken together, our findings suggest that the EGOT

is involved in the progression of HSNCC and seems particularly associated with virus-related forms of HNSCC.
keywords:

eosinophil granule ontogeny transcript, lncRNA, head and neck cancers, biomarker

references:
Cohen N, Fedewa S, Chen AY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am 2018; 30: 381-395.
Jou A, Hess J. Epidemiology and molecular biology of head and neck cancer. Oncol Res Treat 2017; 40: 328-332.
Kolenda T, Przyby³a W, Kapa³czyñska M, et al. Tumor microenvironment – unknown niche with powerful therapeutic potentials. Rep Pract Oncol Radiother 2018; 23: 143-153.
Lasinska I, Kolenda T, Teresiak A, et al. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma
of the Head and Neck. Anticancer Agents Med Chem 2018; doi: 10.2174/1871520618666180910092356.
Lamperska K, Kolenda T, Teresiak A, et al. Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics. PLoS One 2017; 12: e0180265.
Lamperska K, Kozlowski P, Kolenda T, et al. Unpredictable changes of selected miRNA in expression profile of HNSCC. Cancer Biomark. 2016; 16: 55-64.
Kolenda T, Guglas K, Ryœ M, et al. Biological role of long non-coding RNA in head and neck cancers. Rep Pract Oncol Radiother 2017; 22: 378-388.
Guglas K, Bogaczyñska M, Kolenda T, et al. lncRNA in HNSCC:
challenges and potential. Contemp Oncol (Pozn) 2017; 21: 259-266.
Wagner L, Christensen C, Dunn D, et al. EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. Blood 2007; 109: 5191-5198.
Rose D, Stadler PF. Molecular Evolution of the Non-Coding Eosinophil Granule Ontogeny Transcript. Front Genet 2011; 2: 69.
Wu Y, Liang S, Xu B, et al. Long noncoding RNA eosinophil granule ontogeny transcript inhibits cell proliferation and migration and promotes cell apoptosis in human glioma. Exp Ther Med 2017; 14: 3817-3823.
Xu SP, Zhang JF, Sui SY, et al. Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer. Tumor Biol 2015; 36: 9807-9812.
Peng W, Wu J, Fan H, et al. LncRNA EGOT Promotes Tumorigenesis Via Hedgehog Pathway in Gastric Cancer. Pathol Oncol Res 2017; doi: 10.1007/s12253-017-0367-3.
Garitano-Trojaola A, Agirre X, Prósper F, et al. Long Non-Coding RNAs in Haematological Malignancies. Int J Mol Sci 2013; 14: 15386-15422.
Carnero E, Barriocanal M, Prior C, et al. Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication. EMBO Rep 2016; 17: 1013-1028.
Valadkhan S, Fortes P. Regulation of the Interferon Response by lncRNAs in HCV Infection. Front Microbiol 2018; 9: 181.
Tomar S, Graves CA, Altomare D, et al. Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients. Head Neck 2016; 38 Suppl 1: E694-E704.
Zhang C, Pan S, Aisha A, et al. Recombinant human brain natriuretic peptide regulates PI3K/AKT/mTOR pathway through lncRNA EGOT to attenuate hypoxia-induced injury in H9c2 cardiomyocytes. Biochem Biophys Res Commun 2018; 503: 1186-1193.
Greco S, Zaccagnini G, Perfetti A, et al. Long noncoding RNA dysregulation in ischemic heart failure. J Transl Med 2016; 14: 183.
Gao J, Aksoy BA, Dogrusoz U, et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal. Sci Signal 2013; 6: pl1.
Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia 2017; 19: 649-658.
Terai G, Iwakiri J, Kameda T, et al. Comprehensive prediction of lncRNA–RNA interactions in human transcriptome. BMC Genomics 2016; 17 (Suppl 1): 12.
Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
Jin L, Quan J, Pan X, et al. Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma. Mol Med Rep 2017; 16: 7072-7079.
Dok R, Nuyts S. HPV Positive head and neck cancers: molecular pathogenesis and evolving treatment strategies. Cancers (Basel) 2016; 8: pii: E41.
Goedert L, Plaça JR, Nunes EM, et al. Long Noncoding RNAs in HPV-Induced Oncogenesis. Advances in Tumor Virology 2016; 6: 1-9.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe